Table of Contents

 

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

x      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2013

 

OR

 

o         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period                to                

 

Commission File No. 001-33299

 

MELLANOX TECHNOLOGIES, LTD.

(Exact Name of Registrant as Specified in Its Charter)

 

ISRAEL

 

98-0233400

(State or Other Jurisdiction of

 

(I.R.S. Employer

Incorporation or Organization)

 

Identification No.)

 

 

 

BEIT MELLANOX, YOKNEAM, ISRAEL

 

20692

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: +972-4-909-7200

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

 Large accelerated filer x

Accelerated filer o

Non-accelerated filer o

Smaller reporting company o

 

(Do not check if a smaller reporting company)

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes o No x

 

The total number of outstanding shares of the registrant’s Ordinary Shares, nominal value of NIS 0.0175 per share, as of July 25, 2013, was 43,407,653.

 

 

 



Table of Contents

 

MELLANOX TECHNOLOGIES, LTD.

 

 

Page No.

PART I
FINANCIAL INFORMATION

 

 

 

ITEM 1. Unaudited Condensed Consolidated Financial Statements

3

Condensed Consolidated Balance Sheets (Unaudited) — June 30, 2013 and December 31, 2012

3

Condensed Consolidated Statements of Operations (Unaudited) — Three and Six Months Ended June 30, 2013 and 2012

4

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) — Three and Six Months Ended June 30, 2013 and 2012

5

Condensed Consolidated Statements of Cash Flows (Unaudited) — Six Months Ended June 30, 2013 and 2012

6

Notes to Unaudited Condensed Consolidated Financial Statements

7

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

20

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

31

ITEM 4. Controls and Procedures

31

PART II
OTHER INFORMATION

 

ITEM 1. Legal Proceedings

32

ITEM 1A. Risk Factors

32

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

35

ITEM 3. Defaults Upon Senior Securities

35

ITEM 4. Mine Safety Disclosures

35

ITEM 5. Other Information

35

ITEM 6. Exhibits

35

 

2



Table of Contents

 

PART I. FINANCIAL INFORMATION

 

ITEM 1 — UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

MELLANOX TECHNOLOGIES, LTD.

 

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

 

 

June 30,

 

December 31,

 

 

 

2013

 

2012

 

 

 

(In thousands)

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

126,480

 

$

117,054

 

Short-term investments

 

231,062

 

302,593

 

Restricted cash

 

50,356

 

3,229

 

Accounts receivable, net

 

67,602

 

58,516

 

Inventories

 

36,485

 

43,318

 

Deferred taxes and other current assets

 

13,291

 

15,616

 

Total current assets

 

525,276

 

540,326

 

Property and equipment, net

 

68,244

 

62,375

 

Severance assets

 

9,845

 

8,907

 

Intangible assets, net

 

17,344

 

16,134

 

Goodwill

 

132,885

 

132,885

 

Deferred taxes and other long-term assets

 

15,349

 

10,419

 

Total assets

 

$

768,943

 

$

771,046

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

25,968

 

$

37,431

 

Accrued liabilities

 

43,544

 

57,879

 

Deferred revenue

 

12,724

 

12,018

 

Capital lease liabilities, current

 

1,109

 

1,253

 

Total current liabilities

 

83,345

 

108,581

 

Accrued severance

 

12,796

 

11,821

 

Deferred revenue

 

9,170

 

8,366

 

Capital lease liabilities

 

2,284

 

2,835

 

Other long-term liabilities

 

13,833

 

11,635

 

Total liabilities

 

121,428

 

143,238

 

Commitments and Contingencies (Note 7)

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Ordinary shares

 

182

 

178

 

Additional paid-in capital

 

518,893

 

488,365

 

Accumulated other comprehensive income

 

2,165

 

2,794

 

Retained earnings

 

126,275

 

136,471

 

Total shareholders’ equity

 

647,515

 

627,808

 

Total liabilities and shareholders’ equity

 

$

768,943

 

$

771,046

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3



Table of Contents

 

MELLANOX TECHNOLOGIES, LTD.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

(In thousands, except per share data)

 

Total revenues

 

$

98,168

 

$

133,472

 

$

181,248

 

$

222,210

 

Cost of revenues

 

32,168

 

41,700

 

61,116

 

70,588

 

Gross profit

 

66,000

 

91,772

 

120,132

 

151,622

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

38,869

 

37,658

 

77,018

 

66,616

 

Sales and marketing

 

16,797

 

15,810

 

33,211

 

28,615

 

General and administrative

 

10,047

 

6,336

 

17,532

 

11,193

 

Total operating expenses

 

65,713

 

59,804

 

127,761

 

106,424

 

Income (loss) from operations

 

287

 

31,968

 

(7,629

)

45,198

 

Other income, net

 

232

 

221

 

445

 

405

 

Income (loss) before taxes

 

519

 

32,189

 

(7,184

)

45,603

 

Provision for taxes on income

 

(2,258

)

(100

)

(3,012

)

(1,068

)

Net income (loss)

 

$

(1,739

)

$

32,089

 

$

(10,196

)

$

44,535

 

Net income (loss) per share — basic

 

$

(0.04

)

$

0.79

 

$

(0.24

)

$

1.11

 

Net income (loss) per share — diluted

 

$

(0.04

)

$

0.74

 

$

(0.24

)

$

1.04

 

Shares used in per share calculation:

 

 

 

 

 

 

 

 

 

Basic

 

43,284

 

40,860

 

43,093

 

40,165

 

Diluted

 

43,284

 

43,468

 

43,093

 

42,676

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4



Table of Contents

 

MELLANOX TECHNOLOGIES, LTD.

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

(In thousands)

 

Net income (loss)

 

$

(1,739

)

$

32,089

 

$

(10,196

)

$

44,535

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

Change in unrealized gains/losses on available-for-sale securities, net

 

(65

)

(3

)

(7

)

(132

)

Change in unrealized gains/losses on derivative contracts, net

 

(1,055

)

(1,420

)

(622

)

(95

)

Total comprehensive income (loss), net of tax

 

$

(2,859

)

$

30,666

 

$

(10,825

)

$

44,308

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5



Table of Contents

 

MELLANOX TECHNOLOGIES, LTD.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

 

 

Six Months Ended
 June 30,

 

 

 

2013

 

2012

 

 

 

(In thousands)

 

Cash flows from operating activities:

 

 

 

 

 

Net income (loss)

 

$

(10,196

)

$

44,535

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

15,186

 

10,922

 

Deferred income taxes

 

(1,930

)

(2,113

)

Share-based compensation

 

21,540

 

15,687

 

Gain on investments

 

(439

)

(229

)

Excess tax benefits from share-based compensation

 

(1,939

)

(1,794

)

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(9,086

)

(6,404

)

Inventories

 

5,895

 

(6,928

)

Prepaid expenses and other assets

 

2,990

 

691

 

Accounts payable

 

(7,514

)

4,432

 

Accrued liabilities and other payables

 

(9,652

)

23,950

 

Net cash provided by operating activities

 

4,855

 

82,749

 

Cash flows from investing activities:

 

 

 

 

 

Purchase of severance-related insurance policies

 

(412

)

(391

)

Purchases of short-term investments

 

(81,823

)

(156,197

)

Proceeds from sales of short-term investments

 

103,339

 

3,382

 

Proceeds from maturities of short-term investments

 

50,447

 

8,863

 

Decrease (increase) in restricted cash deposits

 

(47,001

)

94

 

Purchase of property and equipment

 

(18,949

)

(10,457

)

Purchase of intangibles

 

(6,327

)

 

Purchase of equity investment in a private company

 

(3,000

)

(1,424

)

Net cash used in investing activities

 

(3,726

)

(156,130

)

Cash flows from financing activities:

 

 

 

 

 

Principal payments on capital lease obligations

 

(695

)

(158

)

Proceeds from exercise of share awards

 

7,053

 

14,295

 

Excess tax benefit from share-based compensation

 

1,939

 

1,794

 

Net cash provided by financing activities

 

8,297

 

15,931

 

Net increase (decrease) in cash and cash equivalents

 

9,426

 

(57,450

)

Cash and cash equivalents at beginning of period

 

117,054

 

181,258

 

Cash and cash equivalents at end of period

 

$

126,480

 

$

123,808

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

Inventory capitalization

 

$

(938

)

$

(507

)

Unpaid property and equipment

 

$

3,949

 

$

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6



Table of Contents

 

MELLANOX TECHNOLOGIES, LTD.

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 — THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

 

Company

 

Mellanox Technologies, Ltd. (the “Company” or “Mellanox”) was incorporated in Israel and commenced operations in March 1999. Mellanox is a supplier of high-performance semiconductor interconnect products for computing, storage and communications applications.

 

Principles of presentation

 

The unaudited condensed consolidated financial statements include the Company’s accounts as well as those of its wholly owned subsidiaries after the elimination of all significant intercompany balances and transactions.

 

The unaudited condensed consolidated financial statements included in this quarterly report on Form 10-Q have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The year-end unaudited condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures contained in this quarterly report comply with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, for a quarterly report on Form 10-Q and are adequate to make the information presented not misleading. The unaudited condensed consolidated financial statements included herein reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012, filed with the SEC on February 25, 2013. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results to be anticipated for the entire year ending December 31, 2013 or thereafter.

 

Risks and uncertainties

 

The Company is subject to all of the risks inherent in a company which operates in the dynamic and competitive semiconductor industry. Significant changes in any of the following areas could have a material adverse impact on the Company’s financial position and results of operations: unpredictable volume or timing of customer orders; ordered product mix; the sales outlook and purchasing patterns of the Company’s customers based on consumer demands and general economic conditions; loss of one or more of the Company’s customers; decreases in the average selling prices of products or increases in the average cost of finished goods; the availability, pricing and timeliness of delivery of components used in the Company’s products; reliance on a limited number of subcontractors to manufacture, assemble, package and production test the Company’s products; the Company’s ability to successfully develop, introduce and sell new or enhanced products in a timely manner; product obsolescence and the Company’s ability to manage product transitions; and the timing of announcements or introductions of new products by the Company’s competitors.

 

Additionally, the Company has a significant presence in Israel, including research and development activities, corporate facilities and sales support operations. Uncertainty surrounding the political, economic and military conditions in Israel may directly impact the Company’s financial results.

 

Use of estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles in United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenues and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to revenue recognition, allowances for doubtful accounts, sales returns and allowances, fair value of financial instruments, short-term investments, warranty reserves, inventory reserves, share-based compensation expense, long-term asset valuations, investments, goodwill and purchased intangible asset

 

7



Table of Contents

 

valuation, deferred income tax asset valuation allowances, uncertain tax positions, litigation and other loss contingencies. These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenue, costs and expenses that are not readily apparent from other sources. The actual results the Company experiences may differ materially and adversely from its original estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected.

 

Significant accounting policies

 

There have been no changes in the Company’s significant accounting policies that were disclosed in its Annual Report on Form 10-K for the fiscal year ended December 31, 2012. See our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the SEC on February 25, 2013, for a discussion of significant accounting policies and estimates.

 

Concentration of credit risk

 

The following table summarizes the revenues from customers (including original equipment manufacturers) in excess of 10% of the total revenues:

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

IBM

 

19

%

19

%

19

%

21

%

Hewlett Packard

 

10

%

30

%

13

%

25

%

 

The following table summarizes the accounts receivable balance in excess of 10% of the total accounts receivable:

 

 

 

June 30,
2013

 

December 31,
2012

 

IBM

 

26

%

21

%

 

At June 30, 2013 and December 31, 2012, based on information filed with the SEC or reported to us, Oracle Corporation held approximately 3.8 million ordinary shares of Mellanox. Sales to Oracle mainly through its contract manufacturers in the three and six months ended June 30, 2013 were $7.9 million and $14.8 million, respectively, and were conducted at arm’s-length. Sales to Oracle mainly through its contract manufacturers in the three and six months ended June 30, 2012 were $6.7 million and $11.5 million, respectively, and were conducted at arm’s-length. At June 30, 2013 and December 31, 2012, accounts receivable from Oracle totaled $0.1 million and $0.2 million, respectively.

 

Product warranty

 

Changes in the Company’s liability for product warranty during the six months ended June 30, 2013 and 2012 are included in Accrued liabilities and are as follows:

 

 

 

Six Months Ended
June 30,

 

 

 

2013

 

2012

 

 

 

(in thousands)

 

Balance, beginning of the period

 

$

4,447

 

$

1,097

 

Warranties issued during the period

 

4,814

 

562

 

Reversal of warranty reserves

 

(909

)

(1

)

Settlements during the period

 

(5,794

)

(372

)

Balance, end of the period

 

$

2,558

 

$

1,286

 

 

8



Table of Contents

 

Net income (loss) per share

 

The following table sets forth the computation of basic and diluted net income (loss) per share for the periods indicated:

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(1,739

)

$

32,089

 

$

(10,196

)

$

44,535

 

Basic and diluted shares:

 

 

 

 

 

 

 

 

 

Weighted average ordinary shares outstanding used to compute basic net income (loss) per share

 

43,284

 

40,860

 

43,093

 

40,165

 

Dilutive effect of employee share option plans

 

 

2,608

 

 

2,511

 

Shares used to compute diluted net income (loss) per share

 

43,284

 

43,468

 

43,093

 

42,676

 

Net income (loss) per share — basic

 

$

(0.04

)

$

0.79

 

$

(0.24

)

$

1.11

 

Net income (loss) per share — diluted

 

$

(0.04

)

$

0.74

 

$

(0.24

)

$

1.04

 

 

The Company excluded 838,270 and 763,810 outstanding shares for the three and six months ended June 30, 2013, respectively, from the computation of diluted net income per ordinary share, because including these outstanding shares would have had an anti-dilutive effect.

 

The Company excluded 135,486 and 428,010 outstanding shares for the three and six months ended June 30, 2012, respectively, from the computation of diluted net income per ordinary share, because including these outstanding shares would have had an anti-dilutive effect.

 

Recent accounting pronouncements

 

Effective January 1, 2013, the Company adopted the authoritative guidance, issued by the Financial Accounting Standards Board (“FASB”) in February 2013, related to reclassifications out of accumulated other comprehensive income (“OCI”). Under this update, an entity is required to report, in one place, information about reclassifications out of accumulated OCI and to report changes in its accumulated OCI balances. For significant items reclassified out of accumulated OCI to net income in their entirety in the same reporting period, reporting is required about the effect of the reclassifications on the respective line items in the statement where net income is presented. For items that are not reclassified to net income in their entirety in the same reporting period, a cross reference to other disclosures currently required under GAAP is required in the notes to the financial statements. The Company elected to present the information in the notes to the Company’s unaudited condensed consolidated financial statements. The adoption of this guidance had no impact on the Company’s consolidated financial statements.

 

9



Table of Contents

 

NOTE 2 — BALANCE SHEET COMPONENTS:

 

 

 

June 30,
2013

 

December 31,
2012

 

 

 

(in thousands)

 

Accounts receivable, net:

 

 

 

 

 

Accounts receivable

 

$

68,241

 

$

59,155

 

Less: allowance for doubtful accounts

 

(639

)

(639

)

 

 

$

67,602

 

$

58,516

 

Inventories:

 

 

 

 

 

Raw materials

 

$

10,337

 

$

6,240

 

Work-in-process

 

11,079

 

4,667

 

Finished goods

 

15,069

 

32,411

 

 

 

$

36,485

 

$

43,318

 

 

 

 

 

 

 

Deferred taxes and other current assets:

 

 

 

 

 

Prepaid expenses

 

$

4,897

 

$

5,346

 

Forward contracts receivable

 

2,320

 

2,942

 

Deferred taxes

 

3,813

 

3,813

 

VAT receivable

 

1,622

 

3,000

 

Other

 

639

 

515

 

 

 

$

13,291

 

$

15,616

 

Property and equipment, net:

 

 

 

 

 

Computer equipment and software

 

$

79,451

 

$

80,203

 

Furniture and fixtures

 

3,794

 

3,890

 

Leasehold improvements

 

29,430

 

26,590

 

 

 

112,675

 

110,683

 

Less: Accumulated depreciation and amortization

 

(44,431

)

(48,308

)

 

 

$

68,244

 

$

62,375

 

 

 

 

 

 

 

Deferred taxes and other long-term assets:

 

 

 

 

 

Equity investments in private companies

 

$

7,424

 

$

4,424

 

Deferred taxes

 

4,013

 

2,083

 

Restricted cash

 

3,440

 

3,388

 

Other assets

 

472

 

524

 

 

 

$

15,349

 

$

10,419

 

Accrued liabilities:

 

 

 

 

 

Payroll and related expenses

 

$

23,337

 

$

37,067

 

Accrued expenses

 

11,239

 

10,104

 

Product warranty liability

 

2,558

 

4,447

 

Other

 

6,410

 

6,261

 

 

 

$

43,544

 

$

57,879

 

Other long-term liabilities:

 

 

 

 

 

Income tax payable

 

$

10,860

 

$

8,838

 

Deferred rent

 

2,873

 

2,797

 

Other

 

100

 

 

 

 

$

13,833

 

$

11,635

 

 

NOTE 3 — FAIR VALUE MEASUREMENTS:

 

Fair value hierarchy

 

The Company measures its cash equivalents and marketable securities at fair value. The Company’s cash equivalents are classified within Level 1. Cash equivalents are valued primarily using quoted market prices utilizing market observable inputs. The Company’s investments in debt securities and certificates of deposits are classified within Level 2 as the market inputs to value these instruments consist of market yields, reported trades and broker/dealer quotes. In addition, foreign currency contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. The Level 3 valuation inputs include the Company’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation. As of June 30, 2013 and December 31, 2012, the Company did not have any financial assets or liabilities valued based on Level 3 valuations.

 

10



Table of Contents

 

The following table presents the fair value hierarchy of the Company’s financial assets measured at fair value as of June 30, 2013. There were no financial liabilities as of June 30, 2013.

 

 

 

Level 1

 

Level 2

 

Total

 

 

 

(in thousands)

 

Certificates of deposits

 

$

 

$

80,396

 

$

80,396

 

U.S. Government and agency securities

 

 

45,964

 

45,964

 

Commercial paper

 

 

70,485

 

70,485

 

Corporate bonds

 

 

78,213

 

78,213

 

Forward contracts

 

 

2,320

 

2,320

 

Total financial assets

 

$

 

$

277,378

 

$

277,378

 

 

The following table presents the fair value hierarchy of the Company’s financial assets measured at fair value as of December 31, 2012. There were no financial liabilities as of December 31, 2012.

 

 

 

Level 1

 

Level 2

 

Total

 

 

 

(in thousands)

 

Certificates of deposit

 

$

 

$

90,431

 

$

90,431

 

U.S. Government and agency securities

 

 

115,129

 

115,129

 

Commercial paper

 

 

34,947

 

34,947

 

Corporate bonds

 

 

61,462

 

61,462

 

Foreign government bonds

 

 

7,530

 

7,530

 

Forward contracts

 

 

2,942

 

2,942

 

Total financial assets

 

$

 

$

312,441

 

$

312,441

 

 

There were no transfers between Level 1 and Level 2 securities during the three and six months ended June 30, 2013.

 

NOTE 4 — INVESTMENTS:

 

Cash, Cash equivalents and Short-term investments

 

The short-term investments are classified as available-for-sale securities. The cash, cash equivalents and short-term investments at June 30, 2013 and December 31, 2012 were as follows:

 

 

 

June 30, 2013

 

 

 

Amortized
Cost

 

Unrealized
Gains

 

Unrealized
Losses

 

Estimated
Fair Value

 

 

 

(in thousands)

 

Cash

 

$

82,484

 

$

 

$

 

$

82,484

 

Certificates of deposits

 

80,405

 

 

(9

)

80,396

 

U.S. Government and agency securities

 

45,994

 

2

 

(32

)

45,964

 

Commercial paper

 

70,480

 

8

 

(3

)

70,485

 

Corporate bonds

 

78,334

 

 

(121

)

78,213

 

Total investments

 

$

357,697

 

$

10

 

$

(165

)

$

357,542

 

Less amounts classified as cash and cash equivalents

 

(126,480

)

 

 

(126,480

)

 

 

$

231,217

 

$

10

 

$

(165

)

$

231,062

 

 

 

 

December 31, 2012

 

 

 

Amortized
Cost

 

Unrealized
Gains

 

Unrealized
Losses

 

Estimated
Fair Value

 

 

 

(in thousands)

 

Cash

 

$

110,148

 

$

 

$

 

$

110,148

 

Certificates of deposits

 

90,437

 

1

 

(7

)

90,431

 

U.S. Government and agency securities

 

115,179

 

9

 

(59

)

115,129

 

Commercial paper

 

34,977

 

 

(30

)

34,947

 

Corporate bonds

 

61,543

 

3

 

(84

)

61,462

 

Foreign government bonds

 

7,511

 

19

 

 

7,530

 

Total investments

 

$

419,795

 

$

32

 

$

(180

)

$

419,647

 

Less amounts classified as cash and cash equivalents

 

(117,054

)

 

 

(117,054

)

 

 

$

302,741

 

$

32

 

$

(180

)

$

302,593

 

 

Realized gains upon the sale of marketable securities were $0.2 million and $0.1 million for the three months ended June 30, 2013 and June 30, 2012, respectively. Realized gains upon the sale of marketable securities were $0.4 million and $0.2 million for the six months ended June 30, 2013 and June 30, 2012, respectively. At June 30, 2013, the investments with gross unrealized losses were not deemed to be other-than-temporarily impaired and the unrealized losses were recorded in OCI.

 

11



Table of Contents

 

The contractual maturities of available-for-sale securities at June 30, 2013 and December 31, 2012 were as follows:

 

 

 

June 30, 2013

 

December 31, 2012

 

 

 

Amortized
Cost

 

Estimated Fair
Value

 

Amortized
Cost

 

Estimated Fair
Value

 

 

 

(in thousands)

 

Due in less than one year

 

$

53,105

 

$

53,082

 

$

58,758

 

$

58,724

 

Due in one to three years

 

178,112

 

177,980

 

243,983

 

243,869

 

 

 

$

231,217

 

$

231,062

 

$

302,741

 

$

302,593

 

 

Restricted cash and deposits

 

The Company maintains certain cash amounts restricted as to withdrawal or use. At June 30, 2013, the Company had $48.5 million in restricted cash designated for acquisition of IPtronics A/S (“IPtronics”). The acquisition was completed on July 1, 2013. The Company also maintained a balance of $0.7 million at June 30, 2013 and December 31, 2012 that represented tenant security deposits restricted due to tenancy agreements, and a balance of $1.2 million and $2.6 million at June 30, 2013 and December 31, 2012, respectively, that represented security deposits restricted due to foreign exchange management agreements with two banks.

 

Investments in privately-held companies

 

As of June 30, 2013, the Company held a total of $7.4 million investments in two privately-held companies. Both of these investments are accounted for under the cost method, net of impairment write down.

 

NOTE 5 — GOODWILL AND INTANGIBLE ASSETS:

 

The following table presents changes in the carrying amount of goodwill (in thousands):

 

Balance as of December 31, 2012

 

$

132,885

 

Adjustments

 

 

Balance as of June 30, 2013

 

$

132,885

 

 

The carrying amounts of intangible assets as of June 30, 2013 were as follows:

 

 

 

Gross
Carrying
Value

 

Accumulated
Amortization

 

Net
Carrying
Value

 

 

 

(in thousands)

 

 

 

 

 

 

 

 

 

Licensed technology

 

$

1,096

 

$

(140

)

$

956

 

Developed technology

 

28,363

 

(18,529

)

9,834

 

Customer relationships

 

10,956

 

(4,402

)

6,554

 

Customer contract

 

1,529

 

(1,529

)

 

Total intangible assets

 

$

41,944

 

$

(24,600

)

$

17,344

 

 

The carrying amounts of intangible assets as of December 31, 2012 are as follows:

 

 

 

Gross
Carrying
Value

 

Accumulated
Amortization

 

Net
Carrying
Value

 

 

 

(in thousands)

 

Licensed technology

 

$

946

 

$

(946

)

$

 

Developed technology

 

23,132

 

(14,695

)

8,437

 

Customer relationships

 

10,956

 

(3,328

)

7,628

 

Customer contract

 

1,529

 

(1,460

)

69

 

Total intangible assets

 

$

36,563

 

$

(20,429

)

$

16,134

 

 

12



Table of Contents

 

Amortization expense of intangible assets was $2.7 million and $2.3 million for the three months ended June 30, 2013 and 2012, respectively. Amortization expense of intangible assets was $5.1 million and $4.7 million for the six months ended June 30, 2013 and 2012, respectively

 

The estimated future amortization expenses from amortizable intangible assets were as follows (in thousands):

 

Remainder of 2013

 

$

5,188

 

2014

 

4,843

 

2015

 

2,081

 

2016

 

1,482

 

2017 and thereafter

 

3,750

 

 

 

$

17,344

 

 

NOTE 6 — DERIVATIVES AND HEDGING ACTIVITIES:

 

The Company uses derivative instruments primarily to manage exposures to foreign currency. The Company enters into forward contracts to manage its exposure to changes in the exchange rate of the New Israeli Shekel (“NIS”) against the U.S. dollar. The Company uses forward contracts designated as cash flow hedges to hedge a substantial portion of future forecasted operating expenses in NIS. The Company’s primary objective in entering into these arrangements is to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The program is not designated for trading or speculative purposes. The Company’s forward contracts expose the Company to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. The Company seeks to mitigate such risk by limiting its counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.

 

The gain or loss on the effective portion of a cash flow hedge is initially reported as a component of accumulated other comprehensive income (loss) (“OCI”), and subsequently reclassified into operating expenses in the same period in which the hedged operating expenses are recognized, or reclassified into other income, net, if the hedged transaction becomes probable of not occurring. Any gain or loss after a hedge is de-designated because it is no longer probable of occurring or related to an ineffective portion of a hedge, as well as any amount excluded from the Company’s hedge effectiveness, is recognized as other income (expense) immediately. As of June 30, 2013, the Company had forward contracts in place that hedged future operating expenses of approximately 143.5 million NIS, or approximately $39.7 million based upon the exchange rate as of June 30, 2013. The forward contracts cover a substantial portion of future NIS denominated operating expenses that the Company expects to incur over the next twelve months.

 

The Company does not use derivative financial instruments for purposes other than cash flow hedges.

 

Fair value of derivative contracts

 

Fair value of derivative contracts as of June 30, 2013 and December 31, 2012 were as follows:

 

 

 

Derivative Assets Reported in
Other Current Assets

 

Derivative Liabilities Reported in
Other Current Liabilities

 

 

 

June 30,
 
2013

 

December 31,
 2012

 

June 30,
 
2013

 

December 31,
 
2012

 

 

 

(in thousands)

 

Foreign exchange contracts designated as cash flow hedges

 

$

2,320

 

$

2,942

 

$

 

$

 

Total derivatives designated as hedging instruments

 

$

2,320

 

$

2,942

 

$

 

$

 

 

Effect of designated derivative contracts on accumulated other comprehensive income

 

The following table presents the balance of designated derivative contracts as cash flow hedges as of June 30, 2013 and December 31, 2012, and their impact on OCI for the six months ended June 30, 2013 (in thousands):

 

December 31, 2012

 

$

2,942

 

Amount of gain recognized in OCI (effective portion)

 

2,359

 

Amount of gain reclassified from OCI to income (effective portion)

 

(2,981

)

June 30, 2013

 

$

2,320

 

 

13



Table of Contents

 

Foreign exchange contracts designated as cash flow hedges relate primarily to operating expenses and the associated gains and losses are expected to be recorded in operating expenses when reclassed out of OCI. The Company expects to realize the accumulated OCI balance related to foreign exchange contracts within the next twelve months.

 

Effect of derivative contracts on the condensed consolidated statement of operations

 

The impact of derivative contracts on total operating expenses in the three and six months ended June 30, 2013 and 2012 was as follows:

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

(In thousands)

 

Gain (loss) on foreign exchange contracts designated as cash flow hedges

 

$

1,702

 

$

(544

)

$

2,981

 

$

(681

)

 

The net gains or losses relating to the ineffective portion of derivative contracts were not material in the three and six months ended June 30, 2013 and 2012.

 

NOTE 7— COMMITMENTS AND CONTINGENCIES:

 

Leases

 

As of June 30, 2013, future minimum lease payments under non-cancelable operating and capital leases were as follows:

 

Year Ended December 31, 

 

Capital
 Leases

 

Operating
 Leases

 

 

 

(in thousands)

 

2013

 

$

569

 

$

8,253

 

2014

 

1,266

 

13,795

 

2015

 

1,117

 

11,063

 

2016

 

500

 

7,055

 

2017 and beyond

 

 

17,211

 

Total minimum lease payments

 

$

3,452

 

$

57,377

 

Less: Amount representing interest

 

(59

)

 

 

Present value of capital lease obligations

 

3,393

 

 

 

Less: Current portion

 

(1,109

)

 

 

Long-term portion of capital lease obligations

 

$

2,284

 

 

 

 

Purchase commitments

 

At June 30, 2013, the Company had non-cancelable purchase commitments of $39.6 million, of which $37.0 million is expected to be paid in the remainder of 2013 and $2.6 million in 2014 and beyond.

 

Acquisition of IPtronics

 

On June 4, 2013, the Company entered into a definitive merger agreement with the shareholders of a privately held company IPtronics, under which the Company agreed to acquire IPtronics for a total cash purchase price of $47.5 million, subject to certain adjustments. The Company completed the acquisition on July 1 2013. In conjunction with this acquisition, the Company assumed all of IPtronic’s restricted stock units, which were converted into equity awards to acquire an aggregate of 60,508 ordinary shares of the Company.

 

14



Table of Contents

 

Acquisition of Kotura

 

On May 14, 2013, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Karate Sub, Inc., a California corporation and wholly owned subsidiary of the Company, Kotura, Inc. (“Kotura”), a California corporation, and GF Private Equity Group, LLC, as the shareholder representative. Pursuant to the Merger Agreement, at the effective time of the acquisition, Karate Sub, Inc. will be merged with and into Kotura, with Kotura, continuing after the merger as the surviving corporation and a wholly owned subsidiary of the Company. The total cash purchase price payable in connection with the merger will be $82 million, subject to certain adjustments. The completion of the merger remains subject to the satisfaction or waiver of certain customary closing conditions.

 

As of June 30, 2013, the Company incurred approximately $1.8 million in legal, accounting and consulting fees associated with the acquisitions of IPtronics and Kotura.

 

Legal proceedings

 

The Company considers all legal claims on a quarterly basis in accordance with GAAP and, based on known facts, assesses whether potential losses are considered reasonably possible, probable and estimable.

 

The Company makes a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least quarterly and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Unless otherwise specifically disclosed in this note, the Company has determined that no provision for liability nor disclosure is required related to any claim against us because: (a) there is not a reasonable possibility that a loss exceeding amounts already recognized (if any) may be incurred with respect to such claim; (b) a reasonably possible loss or range of loss cannot be estimated; or (c) such estimate is immaterial. All legal costs associated with litigation are expensed as incurred.

 

Litigation is inherently unpredictable. However, the Company believes that it has valid defenses with respect to the pending legal matters. It is possible, nevertheless, that the consolidated financial position, cash flows or results of operations could be negatively affected by an unfavorable resolution of one or more of such proceedings, claims or investigations.

 

Pending legal proceedings as of June 30, 2013 were as follows:

 

Avago Technologies Fiber (IP) Singapore Pte. Ltd.

 

On June 29, 2010, Avago Technologies Fiber (IP) Singapore Pte. Ltd. (“Avago IP”) filed a complaint for patent infringement against IPtronics, Inc. and IPtronics A/S (collectively, “Respondents”) in the United States District Court, Northern District of California, San Francisco Division (Case No.: CV- 0-2863). On September 24, 2012, Avago Technologies Fiber (IP) Singapore Pte. Ltd., Avago Technologies General IP (Singapore) Pte. Ltd. and Avago Technologies U.S. Inc. (collectively, “Avago”) filed a complaint against Mellanox Technologies, Ltd., Mellanox Technologies, Inc., IPtronics A/S, IPtronics, Inc., FCI USA, LLC, FCI Deutschland GmbH and FCI SA (collectively, “Respondents”) with the United States International Trade Commission (Inv. No. 337-TA-860). The complaint alleges that the Respondents have engaged in unfair acts in violation of Section 337 of the Tariff Act of 1930, as amended, through allegedly unlicensed importation, sale for importation and/or sale after importation of products covered by patents asserted by Avago.  Pursuant to the complaint, Avago seeks as permanent relief a limited exclusion order barring from entry into the United States, among other Respondent products, all imported Mellanox optoelectronic devices and products containing the same that allegedly infringe the patents asserted by Avago, and a cease and desist order prohibiting the importation, sale, offer for sale, advertising, solicitation, use and/or warehousing of inventory for distribution of such imported products in the United States. Neither the outcome of the proceeding nor the amount and range of potential damages or exposure associated with the proceeding can be assessed with certainty. In the event the Respondents are not successful in defending the Avago claims, the Company could be forced to license technology from Avago and be prevented from importing, selling, offering for sale, advertising, soliciting, using and/or warehousing for distribution the allegedly infringing products.  Based on currently available information, the Company believes that the resolution of this proceeding is not likely to have a material adverse effect on the Company’s business, financial position, results of operations or cash flows.

 

15



Table of Contents

 

Avago Technologies Fiber (IP) Singapore Pte. Ltd. vs. IPtronics Inc. and IPtronics A/S

 

On September 11, 2012, Avago Technologies U.S. Inc., Avago Technologies General IP (Singapore) Pte. Ltd., Avago Technologies Trading Ltd., Avago Technologies International Sales Pte., Ltd., Avago Technologies Fiber (IP) Singapore Pte. Ltd. (collectively, “Avago”) filed a second amended and supplemental complaint (the “Complaint”) against IPtronics, Inc. and IPtronics A/S (collectively, “Respondents”) in the United States District Court, Northern District of California, San Jose Division (Case No.: 5:10-CV-02863-EJD (PSG)). The Complaint amends and supplements all complaints previously filed by Avago in this case and alleges that the Respondents have: infringed certain of Avago’s patents; engaged in violations of the Lanham Act, Section 43 (A); misappropriated Avago’s trade secrets; engaged in unfair competition against Avago; intentionally interfered with Avago’s contractual relations; and was unjustly enriched by and through the conduct complained of by Avago in the Complaint.  Pursuant to the Complaint, Avago seeks unspecified damages, treble damages, injunctive relief and any other relief deemed just and proper by the court. As a result of the acquisition described above under “Acquisition of IPtronics,” IPtronics is a wholly owned subsidiary of the Company as of July 1, 2013. Neither the outcome of the proceeding nor the amount and range of potential damages or exposure associated with the proceeding can be assessed with certainty. In the event the Respondents are not successful in defending the Complaint, the Company could be forced to license technology from Avago and be prevented from importing, selling, offering for sale, advertising, soliciting, using and/or warehousing for distribution the allegedly infringing products. Based on currently available information, the Company believes that the resolution of this proceeding is not likely to have a material adverse effect on the Company’s business, financial position, results of operations or cash flows.

 

In re Mellanox Technologies, Ltd. Securities Litigation

 

On February 7, February 14 and February 22, 2013, Mellanox Technologies, Ltd., the Company’s President and CEO, former CFO and CFO were sued in three separate legal complaints filed in the United States District Court for the Southern District of New York naming the Company and them each as defendants and respectively entitled, Patrick Barnicle, on behalf of himself and others similarly situated v. Mellanox Technologies, Ltd., Eyal Waldman, Michael Gray and Jacob Shulman, Case No. 13 CIV 925, David R. Ryan, Jr., on behalf of himself and others similarly situated v. Mellanox Technologies, Ltd., Eyal Waldman, Michael Gray and Jacob Shulman, Case No. 13 CV 1047 and Valentin Petrov, on behalf of himself and others similarly situated v. Mellanox Technologies, Ltd., Eyal Waldman, Michael Gray and Jacob Shulman, Case No. 13 CV 1225. The complaints were filed by Patrick Barnacle, David R. Ryan and Valentin Petrov, respectively, each for himself as a plaintiff and, purportedly, on behalf of persons purchasing the Company’s ordinary shares between April 19, 2012 and January 2, 2013 (the “Class Period”).

 

On May 14, 2013, the Court consolidated the Barnicle, Ryan and Petrov complaints and appointed lead plaintiffs and lead counsel. The consolidated case is captioned, In re Mellanox Technologies, Ltd. Securities Litigation, Case No. 13-cv-00925 (AKH). On July 12, 2013, an Amended Consolidated Complaint was filed against the same defendants. The Amended Consolidated Complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder. The Amended Consolidated Complaint alleges that, during the Class Period, the defendants made false or misleading statements (or failed to disclose certain facts) regarding the Company’s business and outlook.

 

In the amended complaint, plaintiffs seek unspecified damages, an award of reasonable costs and expenses, including reasonable attorney’s fees, and any other relief deemed just and proper by the court. Based on currently available information, the Company believes that the resolution of this proceeding is not likely to have a material adverse effect on the Company’s business, financial position, results of operations or cash flows.

 

Weinberger Case

 

On February 20, 2013, a request for approval of a class action was filed in the Economic Division of the District Court of Tel Aviv-Jaffa against Mellanox Technologies, Ltd., the Company’s President and CEO, former CFO, CFO and each of the members of the Company’s board of directors (the “Israeli Claim”). The Israeli Claim was filed by Mr. Avigdor Weinberger (the “Claimant”).  The Israeli Claim alleges that the Company, the board members, the Company’s President and CEO, its former CFO and its current CFO are responsible for making misleading statements (or failing to disclose certain facts)  and filings to the public, as a result of which the shares of the Company were allegedly traded at a higher price than their true value during a period commencing on April 19, 2012 and ending January 2, 2013 and, therefore, these parties are responsible for damages caused to the purchasers of the Company’s shares on the Tel Aviv Stock Exchange during this time. The Claimant seeks an award of compensation to the relevant shareholders for all damages caused to them, including attorney fees and Claimant’s fee and any other relief deemed just and proper by the court. On April 24, 2013, the Claimant and the Company filed a procedural agreement with the court to stay the Israeli Claim pending the completion of the Barnicle, Ryan and Petrov cases disclosed herein. On April 24, 2013, the Israeli court approved this procedural agreement and stayed the Israeli proceedings.  Based on currently available information, the Company believes that the resolution of this proceeding is not likely to have a material adverse effect on the Company’s business, financial position, results of operations or cash flows.

 

16



Table of Contents

 

Infinite Data Case

 

On February 19, 2013, Infinite Data LLC, a Delaware limited liability company (“Infinite Data”) and a non-practicing entity and exclusive licensee of U.S. patent number 5,790,530 (the “Patent”), filed suit against approximately 25 of the Company’s end users and direct customers of its InfiniBand products in the United States District Court in Delaware. All approximately 25 actions include the same allegation of infringement regarding the Patent and seek the payment of damages, costs, expenses and injunctive relief. Several of the end users and direct customers sued by Infinite Data have tendered indemnification requests to the Company on the basis of existing contractual or asserted statutory obligations imposed on the Company to provide such indemnification. Based on currently available information, the Company believes that the resolution of these proceedings are not likely to have a material adverse effect on the Company’s business, financial position, results of operations or cash flows.

 

Israeli Class Action Claim in re TASE Delisting

 

On June 6, 2013, a request to certify a class action claim (along with the claim itself) was filed against the Company and its board of directors relating to the delisting of the Company’s shares from the Tel Aviv Stock Exchange (the “TASE”). The name of the claim is Mordechay Turgeman v. Mellanox et. al. (Case No.: 13189-06-13) (the “Claim”). The Claim states that the decision to delist from the TASE was a breach of the duty of care of the directors, as well as a breach of fiduciary duty by the Company’s President and CEO. The Company was served with the complaint on June 16, 2013. An initial hearing regarding the class certification motion has been set for the fiscal fourth quarter 2013. Based on currently available information, the Company believes that the resolution of this claim is not likely to have a material adverse effect on the Company’s business, financial position, results of operations or cash flows.

 

NOTE 8 — SHARE INCENTIVE PLANS:

 

Share option and restricted share units activity

 

The following table summarizes the share option activity under the Company’s equity incentive plans during the six months ended June 30, 2013:

 

 

 

Options Outstanding

 

 

 

Number
of
Shares

 

Weighted
Average
Exercise
Price

 

Outstanding at December 31, 2012

 

3,285,922

 

$

29.74

 

Options granted

 

 

 

Options exercised

 

(240,094

)

12.77

 

Options cancelled

 

(72,582

)

61.18

 

Outstanding at June 30, 2013

 

2,973,246

 

$

30.35

 

 

The total pretax intrinsic value of options exercised in the six months ended June 30, 2013 and 2012 was $9.7 million and $47.4 million, respectively. This intrinsic value represents the difference between the fair market value of the Company’s ordinary shares on the date of exercise and the exercise price of each option. Based on the closing price of the Company’s ordinary shares of $49.50 on June 28, 2013, the total pretax intrinsic value of all outstanding options was $76.9 million.

 

The total pretax intrinsic value of exercisable options at June 30, 2013 was $67.7 million. The total pretax intrinsic value of exercisable options at December 31, 2012 was $88.4 million.

 

Restricted share units activity under the Company’s equity incentive plans in the six months ended June 30, 2013 is set forth below:

 

 

 

Restricted Share Units Outstanding

 

 

 

Number
of
Shares

 

Weighted
Average
Grant Date
Fair Value

 

Non vested restricted share units at December 31, 2012

 

1,763,160

 

$

36.29

 

Restricted share units granted

 

802,040

 

52.01

 

Restricted share units vested

 

(476,711

)

34.79

 

Restricted share units canceled

 

(82,315

)

35.73

 

Non vested restricted share units at June 30, 2013

 

2,006,174

 

$

42.95

 

 

17



Table of Contents

 

The weighted average fair value of restricted share units granted in the three and six months ended June 30, 2013 was $54.51 and $52.01, respectively. The weighted average fair value of restricted share units granted in the three and six months ended June 30, 2012 was $58.23 and $39.44, respectively.

 

The total intrinsic value of all outstanding restricted share units was $99.3 million as of June 30, 2013 and $104.7 million as of December 31, 2012.

 

The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of June 30, 2013:

 

 

 

Number
of
Shares

 

Share options outstanding

 

2,973,246

 

Restricted share units outstanding

 

2,006,174

 

Shares authorized for future issuance

 

1,237,849

 

ESPP shares available for future issuance

 

1,405,497

 

Total shares reserved for future issuance as of June 30, 2013

 

7,622,766

 

 

Share-based compensation

 

The following weighted average assumptions are used to value share options and ESPP shares issued pursuant to the Company’s equity incentive plans for the six months ended June 30, 2013 and 2012:

 

 

 

Employee Share
Options

 

Employee Share
Purchase Plan

 

 

 

Six Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2013 (*)

 

2012

 

2013

 

2012

 

Dividend yield, %

 

 

 

 

 

Expected volatility, %

 

 

56.8

 

64.4

 

49.2

 

Risk free interest rate, %

 

 

0.96

 

0.09

 

0.10

 

Expected life, years

 

 

6.25

 

0.53

 

0.53

 

Estimated forfeiture rate, %

 

 

7.80

 

 

 

 


(*) During the six months ended June 30, 2013 there were no share options granted.

 

The following table summarizes the distribution of total share-based compensation expense in the unaudited condensed consolidated statements of operations:

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

(In thousands)

 

Cost of goods sold

 

$

434

 

$

441

 

$

898

 

$

770

 

Research and development

 

6,442

 

4,519

 

12,250

 

8,700

 

Sales and marketing

 

2,342

 

2,061

 

4,466

 

3,703

 

General and administrative

 

1,947

 

1,424

 

3,926

 

2,514

 

Total share-based compensation expense

 

$

11,165

 

$

8,445

 

$

21,540

 

$

15,687

 

 

At June 30, 2013, there was $100.1 million of total unrecognized share-based compensation costs related to non-vested share-based compensation arrangements. The costs are expected to be recognized over a weighted average period of 2.59 years.

 

At December 31, 2012, there was $84.4 million of total unrecognized share-based compensation costs related to non-vested share-based compensation arrangements. The costs were expected to be recognized over a weighted average period of 2.74 years.

 

18



Table of Contents

 

NOTE 9 — ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS):

 

The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the six months ended June 30, 2013 and June 30, 2012:

 

 

 

Unrealized Gains /
Losses on
Available-for-
Sale Securities

 

Gains / Losses
on Derivatives

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2012

 

$

(148

)

$

2,942

 

$

2,794

 

Other comprehensive income/loss before reclassifications

 

(2

)

2,359

 

2,357

 

Amounts reclassified from accumulated other comprehensive income/loss

 

(5

)

(2,981

)

(2,986

)

Net current-period other comprehensive income/loss, net of taxes

 

(7

)

(622

)

(629

)

Balance at June 30, 2013

 

$

(155

)

$

2,320

 

$

2,165

 

 

 

 

 

 

 

 

 

Balance at December 31, 2011

 

$

(15

)

$

(1,149

)

$

(1,164

)

Other comprehensive income/loss before reclassifications

 

(132

)

(776

)

(908

)

Amounts reclassified from accumulated other comprehensive income/loss

 

 

681

 

681

 

Net current-period other comprehensive income/loss, net of taxes

 

(132

)

(95

)

(227

)

Balance at June 30, 2012

 

$

(147

)

$

(1,244

)

$

(1,391

)

 

The following table provides details about reclassifications out of accumulated other comprehensive income (loss) for the six months ended June 30, 2013:

 

Details about Accumulated Other Comprehensive Income / Loss Components

 

Amount Reclassified from
Other Comprehensive

Income / Loss

 

Affected Line Item in the
Statement of Operations

 

 

 

(in thousands)

 

 

 

Gains on Derivatives

 

$

2,981

 

Cost of revenues and Operating expenses

 

 

 

168

 

Cost of revenues

 

 

 

2,303

 

Research and development

 

 

 

248

 

Sales and marketing

 

 

 

262

 

General and administrative

 

 

 

2,981

 

 

 

Unrealized gains (losses) on Available-for-Sale Securities

 

5

 

Other income, net

 

 

 

 

 

 

 

Total reclassifications for the period

 

$

2,986

 

Total

 

 

NOTE 10 — INCOME TAXES:

 

As of June 30, 2013 and December 31, 2012, the Company had unrecognized tax benefits of $11.9 million and $9.7 million, respectively. It is the Company’s policy to classify accrued interest and penalties as part of the unrecognized tax benefits, or tax contingencies, and record the expense in the provision for income taxes. As of June 30, 2013 and December 31, 2012, the amount of accrued interest and penalties totaled $0.6 million and $0.4 million, respectively. As of June 30, 2013, calendar years 2008 through 2012 were open and subject to potential examination in one or more jurisdictions.

 

19



Table of Contents

 

The Company’s effective tax rate is highly dependent upon the geographic distribution of its worldwide earnings or losses, tax regulations and tax holiday benefits in Israel, and the effectiveness of the Company’s tax planning strategies. The Company’s effective tax rates were 435.1% and (41.9)% for the three and six months ended June 30, 2013, respectively. The Company’s effective tax rates were 0.3% and 2.3% for the three and six months ended June 30, 2012, respectively. The difference between the Company’s effective tax rates for the three and six months ended June 30, 2013 and the 35% federal statutory rate resulted primarily from losses generated from a non-US subsidiary without tax benefit, along with non-tax-deductible expenses such as share-based compensation expense and the accrual of unrecognized tax benefits, and interest and penalties associated with unrecognized tax positions, partially offset by foreign earnings taxed at rates lower than the federal statutory rates.

 

The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and are often ambiguous, and the Company is required to make many subjective assumptions and judgments regarding its income tax exposures. In addition, interpretations of and guidance surrounding income tax laws and regulations are subject to change over time. Any changes in the Company’s subjective assumptions and judgments could materially affect amounts recognized in its consolidated balance sheets and statements of income.

 

NOTE 11 — SUBSEQUENT EVENT:

 

On July 1, 2013, the Company completed the acquisition of IPtronics, for a total cash purchase price of $47.5 million, subject to certain adjustments.

 

The Company will record the purchase of IPtronics using the business combination method of accounting and will recognize the assets acquired and liabilities assumed at their fair values as of the date of the acquisition. The results of IPtronics operations will be included in the Company’s consolidated results of operations beginning July 1, 2013. The Company is currently evaluating the fair values of the consideration transferred, assets acquired and liabilities assumed and will commence its purchase price allocation in the third quarter of fiscal 2013.

 

For more information about this acquisition, see Note 7 of these notes to the unaudited condensed consolidated financial statements.

 

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition as of June 30, 2013 and results of operations for the three and six  months ended June 30, 2013 and June 30, 2012 should be read together with our financial statements and related notes included elsewhere in this report. This discussion and analysis contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that involve risks, uncertainties and assumptions. Words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “predict,” “potential” and similar expressions, as they relate to us, our business and our management, are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this report. The identification of certain statements as “forward-looking” is not intended to mean that other statements not specifically identified are not forward-looking. All statements other than statements about historical facts are statements that could be deemed forward-looking statements, including, but not limited to, statements that relate to our future revenues, product development and introductions, customer demand, our dependence on key customers for a substantial portion of our revenue, performance of our subcontractors, our ability to consummate acquisitions and integrate their operations successfully, growth rates, market adoption of InfiniBand and Ethernet , competitive factors, gross margins, levels of research, development and other related costs, expenditures, protection of our proprietary rights and patents, tax expenses and benefits, cash flows, management’s plans and objectives for current and future operations, conditions in the Middle East and worldwide economic conditions.

 

Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those set forth under the section entitled “Risk Factors” in Part II, Item 1A of this report and in the section entitled “Risk Factors” in Part 1, Item 1A of our Annual Report on Form 10-K for fiscal year ended December 31, 2012. We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. All forward-looking statements included in this report are based on information available to us on the date of this report, and we assume no obligation to update any forward-looking statements contained in this report. Quarterly financial results may not be indicative of the financial results of future periods.

 

20



Table of Contents

 

Unless the context requires otherwise, references in this report to the “Company,” “we,” “us” and “our” refer to Mellanox Technologies, Ltd. and its wholly owned subsidiaries.

 

Overview

 

We are a fabless semiconductor company that produces and supplies high-performance interconnect products that facilitate efficient data transmission between servers, storage systems and communications infrastructure equipment and other embedded systems. We offer adapter, gateway and switch integrated circuits (“ICs”), adapter cards, switch systems, long-haul systems, gateway systems, software, services and cables as an integral part of a total end-to-end networking solution focused on computing, storage and communication applications used in multiple markets, including high-performance computing, or HPC, Web 2.0, storage, financial services, database and cloud. Our adapters and switch ICs provide per port bandwidth up to 10Gb/s, 40Gb/s and 56Gb/s Ethernet, and 10Gb/s (Single Data Rate or SDR), 20Gb/s (Double Data Rate or DDR), 40Gb/s (Quad Data Rate or QDR) and 56Gb/s (Fourteen Data Rate or FDR) InfiniBand. Our switch systems range in port density from 8, 18, 36, 48 and 64 port top-of-rack switches to director-class switches ranging in size from 108 to 648 ports. Connectivity between the adapters and switches is supported with our short reach copper cables and long reach active optical cables, and our management software provides visibility, monitoring and diagnostics for the system.

 

We are one of the pioneers of InfiniBand, an industry-standard architecture that provides specifications for high-performance interconnects. We believe InfiniBand interconnect solutions deliver industry-leading performance, efficiency and scalability of clustered computing and storage systems that incorporate our products. In addition to supporting InfiniBand, our products also support industry-standard Ethernet transmission protocols providing unique product differentiation and connectivity flexibility. Our products serve as building blocks for creating reliable and scalable InfiniBand and Ethernet solutions with leading performance.

 

On May 14, 2013, we entered into a definitive merger agreement with Kotura, Inc, among others, pursuant to which Kotura, Inc. will become a wholly owned subsidiary of the Company for a total cash purchase price of $82 million, subject to certain adjustments. The completion of the acquisition remains subject to the satisfaction or waiver of certain customary closing conditions. The acquisition is expected to expand our ability to deliver cost-effective, high-speed networks with next generation optical connectivity. Kotura has an assembled workforce and a strong patent portfolio in the field of silicon photonics; a technology we expect to enhance our ability to offer interconnect solutions at per port bandwidths of 100 Gb/s and beyond.

 

On July 1, 2013, we completed the acquisition of IPtronics, for a total cash purchase price of $47.5 million, subject to adjustments. We believe that the acquisition enhances our ability to deliver cost-effective, high-speed networks with next generation optical connectivity at 100Gb/s and beyond. The acquisition is expected to increase our competiveness and position as a leading provider of high-performance, end-to-end interconnect solutions for servers and storage systems.

 

Revenues. We derive revenues from sales of our ICs, cards, switch systems, cables, software and accessories. Our sales have historically been made on the basis of purchase orders rather than long-term agreements. Revenues were $181.2 million for the six months ended June 30, 2013, compared to $222.2 million for the six months ended June 30, 2012, representing a decrease of approximately 18%. The year-over-year revenue decrease was primarily due to increased revenues in the six months ended June 30, 2012 related to pent up demand associated with the launch of Romley and Sandy Bridge platforms by Intel Corporation. In addition, our revenues in the six months ended June 30, 2013 were negatively impacted by depletion of inventory accumulated at an OEM customer during the second half of 2012. Our revenues for the six months ended June 30, 2013 are not necessarily indicative of future results.

 

Our products have broad adoption with multiple end customers across HPC, Web 2.0, cloud, EDC, financial services and storage markets, however, these markets are mainly served by leading server, storage and communications infrastructure OEMs. Therefore, we have derived a substantial portion of our revenues from a relatively small number of OEM customers. Sales to our top ten customers represented 70% and 82% of our total revenues for the six months ended June 30, 2013 and 2012, respectively. Sales to customers representing 10% or more of revenues accounted for 32% and 46% of our total revenues for the six months ended June 30, 2013 and 2012, respectively. The loss of one or more of our principal customers, the reduction or deferral of purchases, or changes in the mix of our products ordered by any one of these customers could cause our revenues to decline materially if we are unable to increase our revenues from other customers. Our customers, including our most significant customers, are not obligated by long-term contracts to purchase our products and may cancel orders with limited potential penalties. If any of our large customers reduces or cancels its purchases from us for any reason, it could have an adverse effect on our revenues and results of operations.

 

At June 30, 2013 and December 31, 2012, based on information filed with the SEC or reported to us, Oracle Corporation held approximately 3.8 million of our ordinary shares. Sales to Oracle mainly through its contract manufacturers in the six months ended June 30, 2013 and 2012 were $14.8 million and $11.5 million, respectively, and were conducted at arm’s-length. There were no other material transactions with Oracle during the six months ended June 30, 2013 and 2012. At June 30, 2013 and December 31, 2012, accounts receivable from Oracle totaled $0.1 million and $0.2 million, respectively.

 

21



Table of Contents

 

Cost of revenues and gross profit. The cost of revenues consists primarily of the cost of silicon wafers purchased from our foundry supplier, costs associated with the assembly, packaging and production testing of our ICs, outside processing costs associated with the manufacture of our adapter cards, and switch systems, purchased cable costs, royalties due to third parties, warranty costs, excess and obsolete inventory costs, depreciation and amortization, and costs of personnel associated with production management, quality assurance and services. In addition, after we purchase wafers from our foundries, we also face yield risk related to manufacturing these wafers into semiconductor devices. Manufacturing yield is the percentage of acceptable product resulting from the manufacturing process, as identified when the product is tested as a finished IC. If our manufacturing yields decrease, our cost per unit increases, which could have a significant adverse impact on our cost of revenues. We do not have long-term pricing agreements with foundry suppliers and contract manufacturers. Accordingly, our costs are subject to price fluctuations based on the overall cyclical demand for semiconductors.

 

We purchase our inventory pursuant to standard purchase orders. We estimate that lead times for delivery of our finished semiconductors from our foundry supplier and assembly, packaging and production testing subcontractor are approximately three to four months, lead times for delivery from our adapter card manufacturing subcontractor are approximately eight to ten weeks, and lead times for delivery from our switch systems manufacturing subcontractors are approximately twelve weeks. We build inventory based on forecasts of customer orders rather than the actual orders themselves.

 

We expect our cost of revenues as a percentage of sales to increase in the future as a result of a reduction in the average sale price of our products and a higher percentage of revenue deriving from sales of switch systems and cables, which generally yield lower gross margins. This trend will depend on overall customer demand for our products, our product mix, composition of our revenues by respective data rate, competitive product offerings and related pricing and our ability to reduce manufacturing costs

 

Operational Expenses

 

Research and Development Expenses.  Our research and development expenses consist primarily of salaries, share-based compensation and associated costs for employees engaged in research and development, costs associated with computer aided design software tools, depreciation, allocable facilities and administrative expenses and tape-out costs. Tape-out costs are expenses related to the manufacture of new ICs, including charges for mask sets, prototype wafers, mask set revisions and testing incurred before releasing new ICs into production. We anticipate that our research and development expenses will increase as we continue to invest in development of new products and technologies.

 

Sales and Marketing Expenses. Sales and marketing expenses consist primarily of salaries, incentive compensation, share-based compensation and associated costs for employees engaged in sales, marketing and business development, commission payments to external sales representatives, advertising, and charges for trade shows, promotions, travel and allocable facilities and administrative expenses. We expect these expenses will increase in absolute dollars in future periods based on an increase in sales, marketing and business development personnel and increased marketing activities.

 

General and Administrative Expenses. General and administrative expenses consist primarily of salaries, share-based compensation and associated costs for employees engaged in finance, legal, human resources and administrative activities, and other professional service expenses for accounting, corporate legal fees and allocable facilities expenses. We expect these expenses will increase in absolute dollars in future periods based on an increase in personnel to support our business activities.

 

Amortization of Intangible Assets. Amortization of intangible assets relates to intangible assets resulting from our acquisition of Voltaire Ltd. and purchases of patents and other license rights, which will be amortized over their estimated useful lives. Amortization is included in cost of revenues, research and development, sales and marketing or general and administrative expenses based upon the nature of the intangible asset.

 

Taxes on Income. Our operations in Israel have been granted “Approved Enterprise” status by the Investment Center of the Israeli Ministry of Industry, Trade and Labor and “Beneficiary Enterprise” status by the Israeli Income Tax Authority, which makes us eligible for tax benefits under the Israeli Law for Encouragement of Capital Investments, 1959. Under the terms of the Beneficiary Enterprise program, income that is attributable to our operations in Yokneam, Israel will be exempt from income tax for a period of ten years commencing fiscal year 2011. Income that is attributable to our operations in Tel Aviv, Israel is subject to a reduced income tax rate (generally 10 to 25%, depending on the percentage of foreign investment in the Company) for five to eight years beginning fiscal year 2013. The Yokneam tax holiday is expected to expire in 2020 and the Tel Aviv tax holiday is expected to expire between 2015 and 2018.

 

22



Table of Contents

 

In the first quarter of 2013, we realigned some of our business activities and, as a result, may utilize carryforward net operating losses in one of our subsidiaries in the future. The valuation allowance established for deferred tax assets will be released if it becomes more likely than not the subsidiary will generate sufficient future taxable income.

 

Critical Accounting Policies and Estimates

 

Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates.

 

We believe that the assumptions and estimates associated with revenue recognition, allowance for doubtful accounts, fair value of financial instruments, short-term investments, warranty reserves, inventory reserves, share-based compensation expense, long-term asset valuations, investments, goodwill and purchased intangible asset valuation, deferred income tax asset valuation allowances, uncertain tax positions, litigation and other loss contingencies have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates. For further information on all of our significant accounting policies, please see Note 1 of the accompanying notes to our consolidated financial statements.

 

See our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the SEC on February 25, 2013, for a discussion of additional critical accounting policies and estimates. There have been no changes in our critical accounting policies as compared to what was disclosed in the Form 10-K for the year ended December 31, 2012.

 

Results of Operations

 

The following table sets forth our consolidated statements of operations as a percentage of revenues for the periods indicated:

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

Total revenues

 

100

%

100

%

100

%

100

%

Cost of revenues

 

33

 

31

 

34

 

32

 

Gross profit

 

67

 

69

 

66

 

68

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

40

 

28

 

42

 

30

 

Sales and marketing

 

17

 

12

 

18

 

13

 

General and administrative

 

10

 

5

 

10

 

5

 

Total operating expenses

 

67

 

45

 

70

 

48

 

Income (loss) from operations

 

0

 

24

 

(4

)

20

 

Other income, net

 

0

 

0

 

0

 

0

 

Provision for taxes on income

 

(2

)

(0

)

(2

)

(0

)

Net income (loss)

 

(2

)%

24

%

(6

)%

20

%

 

Comparison of the Three Months Ended June 30, 2013 to the Three Months Ended June 30, 2012

 

The following table represents our total revenues for the three months ended June 30, 2013 and 2012 by product category, interconnect protocol and data rate.

 

 

 

Three Months Ended June 30,

 

Product category:

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(in thousands)

 

 

 

(in thousands)

 

 

 

ICs

 

$

13,559

 

13.8

%

$

19,333

 

14.5

%

Boards

 

30,131

 

30.7

%

44,029

 

33.0

%

Switch and gateway systems

 

39,051

 

39.8

%

47,408

 

35.5

%

Cables, accessories and other

 

15,427

 

15.7

%

22,702

 

17.0

%

Total revenue

 

$

98,168

 

100.0

%

$

133,472

 

100.0

%

 

23



Table of Contents

 

 

 

Three Months Ended June 30,

 

Interconnect protocol and data rate:

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(in thousands)

 

 

 

(in thousands)

 

 

 

InfiniBand:

 

 

 

 

 

 

 

 

 

FDR

 

$

50,754

 

51.7

%

$

72,012

 

54.0

%

QDR

 

24,935

 

25.4

%

41,860

 

31.4

%

DDR

 

4,394

 

4.5

%

6,454

 

4.8

%

SDR

 

713

 

0.7

%

613

 

0.4

%

Total

 

80,796

 

82.3

%

120,939

 

90.6

%

Ethernet

 

13,941

 

14.2

%

9,690

 

7.3

%

Other

 

3,431

 

3.5

%

2,843

 

2.1

%

Total revenue

 

$

98,168

 

100.0

%

$

133,472

 

100.0

%

 

Revenues. Revenues were $98.2 million for the three months ended June 30, 2013 compared to $133.5 million for the three months ended June 30, 2012, representing a decrease of 26.5%. The year-over-year revenue decrease was primarily due to increased revenues in the three months ended June 30, 2012 related to pent up demand associated with the launch of Romley and Sandy Bridge platforms by Intel Corporation.  Revenues for the three months ended June 30, 2013 are not necessarily indicative of future results.

 

Gross Profit and Margin. Gross profit was $66.0 million for the three months ended June 30, 2013 compared to $91.8 million for the three months ended June 30, 2012, representing a decrease of 28.1%. As a percentage of revenues, gross margin decreased to 67.2% in the three months ended June 30, 2013 from 68.8% in the three months ended June 30, 2012. The gross margin percentage decrease was mainly due to product mix and increased warranty expenses associated with our expansion into new markets. Specifically, the portion of revenues attributed to ICs and boards declined in the three months ended June 30, 2013 while the portion of revenues attributable to switch and gateway systems increased. We garnish higher gross margins on sales of ICs and boards. Gross margin for the three months ended June 30, 2013 is not necessarily indicative of future results.

 

Research and Development.

 

The following table presents details of our research and development expenses for the periods indicated:

 

 

 

Three Months Ended June 30,

 

 

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(In thousands)

 

 

 

(In thousands)

 

 

 

Salaries and benefits

 

$

19,080

 

19.4

%

$

21,054

 

15.8

%

Share-based compensation

 

6,442

 

6.6

%

4,519

 

3.4

%

Development and tape-out costs

 

4,337

 

4.4

%

5,044

 

3.8

%

Other research and development costs

 

9,010

 

9.2

%

7,041

 

5.2

%

Total research and development

 

$

38,869

 

39.6

%

$

37,658

 

28.2

%

 

Research and development expenses were $38.9 million in the three months ended June 30, 2013 compared to $37.7 million in the three months ended June 30, 2012, representing an increase of 3.2%. The decrease in salaries and benefits related expense was primarily due to lower accrued bonuses partially offset by higher payroll expenses due to an increase in headcount. The increase in share-based compensation was attributable to restricted share units granted to existing employees in the first quarter of fiscal 2013, as well as new hires. Development and tape-out costs were lower in the second quarter of 2013 primarily due to lower mask and software costs. The increase in other research and development costs was primarily attributable to higher depreciation and amortization expenses, as well as increased facilities and maintenance expenses. We expect that research and development expenses will increase in absolute dollars in future periods as we continue to devote more resources to develop new products, meet the changing requirements of our customers, expand into new markets and technologies and hire additional personnel.

 

24



Table of Contents

 

For a further discussion of share-based compensation included in research and development expense, see “Share-based Compensation Expense” below.

 

Sales and Marketing.

 

The following table presents details of our sales and marketing expenses for the periods indicated:

 

 

 

Three Months Ended June 30,

 

 

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(In thousands)

 

 

 

(In thousands)

 

 

 

Salaries and benefits

 

$

9,077

 

9.2

%

$

8,129

 

6.1

%

Share-based compensation

 

2,342

 

2.4

%

2,061

 

1.5

%

Trade shows and promotions

 

2,620

 

2.7

%

3,037

 

2.3

%

Other sales and marketing costs

 

2,758

 

2.8

%

2,583

 

1.9

%

Total sales and marketing

 

$

16,797

 

17.1

%

$

15,810

 

11.8

%

 

Sales and marketing expenses were $16.8 million for the three months ended June 30, 2013 compared to $15.8 million for the three months ended June 30, 2012, representing an increase of 6.2%. The increase in salaries and benefits and share-based compensation was attributable to headcount additions partially offset by lower accrued bonuses. The decrease in trade show and promotion costs was primarily due to lower external sales commission and a decrease in expenses related to equipment for customer product evaluations. The increase in other sales and marketing costs was primarily attributable to higher depreciation and amortization expenses, as well as increased facilities and maintenance expenses.

 

For a further discussion of share-based compensation included in sales and marketing expense, see “Share-based Compensation Expense” below.

 

General and Administrative.

 

The following table presents details of our general and administrative expenses for the periods indicated:

 

 

 

Three Months Ended June 30,

 

 

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(In thousands)

 

 

 

(In thousands)

 

 

 

Salaries and benefits

 

$

2,509

 

2.6

%

$

3,003

 

2.3

%

Share-based compensation

 

1,947

 

2.0

%

1,424

 

1.1

%

Professional services

 

4,655

 

4.7

%

535

 

0.4

%

Other general and administrative costs

 

936

 

0.9

%

1,374

 

0.9

%

Total general and administrative

 

$

10,047

 

10.2

%

$

6,336

 

4.7

%

 

General and administrative expenses were $10.0 million for the three months ended June 30, 2013 compared to $6.3 million for the three months ended June 30, 2012, representing an increase of 58.6%. The decrease in salaries and benefits related expense was due to lower accrued bonuses partially offset by higher payroll expenses as a result of increased headcount. The increase in share-based compensation was attributable to restricted share units granted to existing employees in the first quarter of fiscal 2013, as well as new hires. The increase in professional services costs was primarily due to $1.8 million of legal, accounting and consulting fees associated with the acquisitions of IPtronics and Kotura, as well as legal expenses related to the legal proceedings in which we are currently involved. The decrease in other general and administrative costs was due to lower human resources related costs.

 

For a further discussion of share-based compensation included in general and administrative expense, see “Share-based Compensation Expense” below.

 

25



Table of Contents

 

Share-based Compensation Expense.

 

The following table summarizes the distribution of total share-based compensation expense in the consolidated statements of operations:

 

 

 

Three Months Ended
June 30,

 

 

 

2013

 

2012

 

 

 

(In thousands)

 

Cost of goods sold

 

$

434

 

$

441

 

Research and development

 

6,442

 

4,519

 

Sales and marketing

 

2,342

 

2,061

 

General and administrative

 

1,947

 

1,424

 

Total share-based compensation expense

 

$

11,165

 

$

8,445

 

 

Share-based compensation expenses were $11.2 million for the three months ended June 30, 2013, compared to $8.4 million for the three months ended June 30, 2012, representing an increase of 32.2%. The increase in share-based compensation expense was primarily due to restricted share units granted to existing employees in the first quarter of fiscal 2013 and new hires.

 

At June 30, 2013, there were $100.1 million of total unrecognized share-based compensation costs related to non-vested share-based compensation arrangements. The costs are expected to be recognized over a weighted average period of 2.59 years.

 

At June 30, 2012, there were $70.3 million of total unrecognized share-based compensation costs related to non-vested share-based compensation arrangements. The costs were expected to be recognized over a weighted average period of 3.36 years.

 

Other Income, Net. Other income, net consists of interest earned on cash and cash equivalents and short-term investments and foreign currency exchange gains and losses. Other income, net was $0.2 million for the three months ended June 30, 2013 and June 30, 2012.

 

Provision for Taxes on Income. Provision for taxes on income was $2.3 million for the three months ended June 30, 2013, compared to $0.1 million for the three months ended June 30, 2012. The effective tax rate was approximately 435.1% and 0.3% for the three months ended June 30, 2013 and 2012, respectively. The difference between our effective tax rates and the 35% federal statutory rate resulted primarily from losses generated from a non-US subsidiary without tax benefit, along with non-tax-deductible expenses such as share-based compensation expense and the accrual of unrecognized tax benefits, and interest and penalties associated with unrecognized tax positions, partially offset by foreign earnings taxed at rates lower than the federal statutory rates.

 

Comparison of the Six Months Ended June 30, 2013 to the Six Months Ended June 30, 2012

 

The following table represents our total revenues for the six months ended June 30, 2013 and 2012 by product category, interconnect protocol and data rate.

 

 

 

Six Months Ended June 30,

 

Product category:

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(In thousands)

 

 

 

(In thousands)

 

 

 

ICs

 

$

24,657

 

13.6

%

$

34,271

 

15.4

%

Boards

 

53,799

 

29.7

%

72,194

 

32.5

%

Switch systems and gateways

 

74,609

 

41.2

%

78,822

 

35.5

%

Cables, accessories and other

 

28,183

 

15.5

%

36,923

 

16.6

%

Total revenue

 

$

181,248

 

100.0

%

$

222,210

 

100.0

%

 

 

 

 

Six Months Ended June 30,

 

Interconnect protocol and data rate:

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(In thousands)

 

 

 

(In thousands)

 

 

 

InfiniBand:

 

 

 

 

 

 

 

 

 

FDR

 

$

92,585

 

51.1

%

$

99,742

 

44.9

%

QDR

 

49,897

 

27.5

%

82,156

 

37.0

%

DDR

 

8,037

 

4.4

%

14,503

 

6.5

%

SDR

 

1,216

 

0.7

%

845

 

0.4

%

Total

 

151,735

 

83.7

%

197,246

 

88.8

%

Ethernet

 

21,781

 

12.0

%

18,361

 

8.3

%

Other

 

7,732

 

4.3

%

6,603

 

2.9

%

Total revenue

 

$

181,248

 

100.0

%

$

222,210

 

100.0

%

 

26



Table of Contents

 

Revenues. Revenues were $181.2 million for the six months ended June 30, 2013 compared to $222.2 million for the six months ended June 30, 2012, representing a decrease of 18.4%. The year-over-year revenue decrease was primarily due to increased revenues in the six months ended June 30, 2012 related to pent up demand associated with the launch of Romley and Sandy Bridge platforms by Intel Corporation. In addition, our revenues in the six months ended June 30, 2013 were negatively impacted by the depletion of inventory accumulated at an OEM customer during the second half of 2012. Revenues for the six months ended June 30, 2013 are not necessarily indicative of future results.

 

Gross Profit and Margin. Gross profit was $120.1 million for the six months ended June 30, 2013 compared to $151.6 million for the six months ended June 30, 2012, representing a decrease of 20.8%. As a percentage of revenues, gross margin decreased to 66.3% in the six months ended June 30, 2013 from 68.2% in the six months ended June 30, 2012. The gross margin percentage decrease was mainly due to product mix and increased warranty expenses associated with our expansion into new markets. Specifically, the portion of revenues attributed to ICs and boards declined in the six months ended June 30, 2013 while the portion of revenues attributable to switch and gateway systems increased. We garnish higher gross margins on sales of ICs and boards. Gross margin for the six months ended June 30, 2013 is not necessarily indicative of future results.

 

Research and Development.

 

The following table presents details of our research and development expenses for the periods indicated:

 

 

 

Six Months Ended June 30,

 

 

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(In thousands)

 

 

 

(In thousands)

 

 

 

Salaries and benefits

 

$

37,629

 

20.8

%

$

37,205

 

16.7

%

Share-based compensation

 

12,250

 

6.8

%

8,700

 

3.9

%

Development and tape-out costs

 

9,703

 

5.3

%

8,043

 

3.6

%

Other research and development costs

 

17,436

 

9.6

%

12,668

 

5.8

%

Total research and development

 

$

77,018

 

42.5

%

$

66,616

 

30.0

%

 

Research and development expenses were $77.0 million in the six months ended June 30, 2013 compared to $66.6 million in the six months ended June 30, 2012, representing an increase of 15.6%. The increase in salaries and benefits and share-based compensation was attributable to headcount additions partially offset by lower accrued bonuses. Development and tape-out costs were higher primarily due to increased outsourcing, product development expenses, equipment expenses and higher software costs. The increase in other research and development costs was primarily attributable to an increase in depreciation and amortization, as well as higher facilities and maintenance expense. We expect that research and development expenses will increase in absolute dollars in future periods as we continue to devote more resources to develop new products, meet the changing requirements of our customers, expand into new markets and technologies and hire additional personnel.

 

For a further discussion of share-based compensation included in research and development expense, see “Share-based Compensation Expense” below.

 

Sales and Marketing.

 

The following table presents details of our sales and marketing expenses for the periods indicated:

 

 

 

Six Months Ended June 30,

 

 

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(In thousands)

 

 

 

(In thousands)

 

 

 

Salaries and benefits

 

$

18,391

 

10.1

%

$

15,035

 

6.8

%

Share-based compensation

 

4,466

 

2.5

%

3,703

 

1.6

%

Trade shows and promotions

 

5,165

 

2.8

%

5,044

 

2.3

%

Other sales and marketing costs

 

5,189

 

2.9

%

4,833

 

2.2

%

Total sales and marketing

 

$

33,211

 

18.3

%

$

28,615

 

12.9

%

 

27



Table of Contents

 

Sales and marketing expenses were $33.2 million for the six months ended June 30, 2013 compared to $28.6 million for the six months ended June 30, 2012, representing an increase of 16.1%. The increase in salaries and benefits and share-based compensation was attributable to headcount additions partially offset by lower accrued bonuses. The increase in trade show and promotion costs was primarily due to an increase in advertising expenses partially offset by lower external sales commissions. The increase in other sales and marketing costs was primarily attributable to higher depreciation and amortization and an increase in facilities and maintenance costs.

 

For a further discussion of share-based compensation included in sales and marketing expense, see “Share-based Compensation Expense” below.

 

General and Administrative.

 

The following table presents details of our general and administrative expenses for the periods indicated:

 

 

 

Six Months Ended June 30,

 

 

 

2013

 

% of
 Revenues

 

2012

 

% of
 Revenues

 

 

 

(In thousands)

 

 

 

(In thousands)

 

 

 

Salaries and benefits

 

$

5,046

 

2.8

%

$

5,227

 

2.4

%

Share-based compensation

 

3,926

 

2.2

%

2,514

 

1.1

%

Professional services

 

6,423

 

3.5

%

1,755

 

0.8

%

Other general and administrative costs

 

2,137

 

1.2

%

1,697

 

0.7

%

Total general and administrative

 

$

17,532

 

9.7

%

$

11,193

 

5.0

%

 

General and administrative expenses were $17.5 million for the six months ended June 30, 2013 compared to $11.2 million for the three months ended June 30, 2012, representing an increase of 56.6%. The increase in share-based compensation was attributable to restricted share units granted to existing employees in the first quarter of fiscal 2013, as well as new hires. The increase in professional services costs was primarily due to $1.8 million of legal, accounting and consulting fees associated with the acquisitions of IPtronics and Kotura, as well as legal expenses related to the legal proceedings in which the Company is currently involved. The decrease in salaries and benefits was primarily due to lower accrued bonuses. The increase in other general and administrative costs was due to higher facilities and maintenance expenses.

 

For a further discussion of share-based compensation included in general and administrative expense, see “Share-based Compensation Expense” below.

 

Share-based Compensation Expense.

 

The following table summarizes the distribution of total share-based compensation expense in the consolidated statements of operations:

 

 

 

Six months ended
 June 30,

 

 

 

2013

 

2012

 

 

 

(In thousands)

 

Cost of goods sold

 

$

898

 

$

770

 

Research and development

 

12,250

 

8,700

 

Sales and marketing

 

4,466

 

3,703

 

General and administrative

 

3,926

 

2,514

 

Total share-based compensation expense

 

$

21,540

 

$

15,687

 

 

28



Table of Contents

 

Share-based compensation expenses were $21.5 million for the six months ended June 30, 2013, compared to $15.7 million for the six months ended June 30, 2012, representing an increase of 37.3%. The increase in share-based compensation expense was primarily due to restricted share units granted to existing employees in the first quarter of fiscal 2013 and new hires.

 

Other Income, Net. Other income, net consists of interest earned on cash and cash equivalents, short-term investments and foreign currency exchange gains and losses. Other income, net was $0.4 million for the six months ended June 30, 2013 and June 30, 2012.

 

Provision for Taxes on Income. Provision for taxes on income was $3.0 million for the six months ended June 30, 2013, compared to $1.1 million for the six months ended June 30, 2012. The effective tax rate was approximately (41.9)% and 2.3% for the six months ended June 30, 2013 and 2012, respectively. The difference between our effective tax rates and the 35% federal statutory rate resulted primarily from losses generated from a non-US subsidiary without tax benefit, along with non-tax-deductible expenses such as share-based compensation expense and the accrual of unrecognized tax benefits, and interest and penalties associated with unrecognized tax positions, partially offset by foreign earnings taxed at rates lower than the federal statutory rates, partially offset by foreign earnings taxed at rates lower than the federal statutory rates.

 

Liquidity and Capital Resources

 

Historically, we have financed our operations through a combination of sales of equity securities and cash generated by operations. As of June 30, 2013, our principal source of liquidity consisted of cash and cash equivalents of $126.5 million, short-term investments of $231.1 million and restricted cash of $48.5 million designated for acquisition of IPtronics. The acquisition closed on July 1, 2013 and our restricted cash decreased accordingly. Also during the fiscal third quarter, we expect to close the acquisition of Kotura and finance it from our existing capital resources. We expect that our current cash, cash equivalents, short-term investments, and cash flows from operating activities will be sufficient to fund our operations over the next twelve months after taking into account expected increases in research and development expenses, including tape out costs, higher sales and marketing and general and administrative expenses, and capital expenditures to support our infrastructure and growth.

 

Our cash position, short-term investments, restricted cash and working capital at June 30, 2013 and December 31, 2012 were as follows:

 

 

 

June 30, 2013

 

December 31, 2012

 

 

 

(in thousands)

 

Cash and cash equivalents

 

$

126,480

 

$

117,054

 

Short-term investments

 

231,062

 

302,593

 

Restricted cash, current

 

50,356

 

3,229

 

Restricted cash, long-term

 

3,440

 

3,388

 

Total

 

$

411,338

 

$

426,264

 

 

 

 

 

 

 

Working capital

 

$

441,931

 

$

431,745

 

 

Our ratio of current assets to current liabilities was 6.3:1 at June 30, 2013 compared to 5.0:1 at December 31, 2012.

 

Operating activities

 

Net cash provided by our operating activities amounted to $4.9 million and $82.7 million in the six months ended June 30, 2013 and 2012, respectively. Net cash provided by operating activities in the six months ended June 30, 2013 was primarily attributable to net non-cash items of $32.4 million partially offset by changes in assets and liabilities of $17.3 million and net loss of $10.2 million. Non-cash expenses consisted primarily of $19.6 million of share-based compensation, net of the excess tax benefits, and $15.2 million for depreciation and amortization, partially offset by deferred income taxes of $1.9 million. The $17.3 million cash outflow from changes in assets and liabilities resulted from a decrease of $9.7 million in accrued liabilities primarily due to the payment of accrued bonuses for fiscal year 2012, an increase in accounts receivable of $9.1 million and a decrease in accounts payable of $7.5 million primarily due to payments to contract manufacturers for inventory purchased in fiscal 2012, partially offset by an decrease in inventories of $5.9 million as we continued to fulfill customer orders from existing inventories and a decrease in prepaid expenses and other assets by $3.0 million.

 

29



Table of Contents

 

Net cash provided by operating activities amounted to $82.7 million in the six months ended June 30, 2012 and was primarily attributable to net income of $44.5 million, adjusted by net non-cash items of $22.5 million and changes in assets and liabilities of $15.7 million. Non-cash expenses consisted primarily of $13.9 million of share-based compensation, net of the excess tax benefits, and $10.9 million for depreciation and amortization, partially offset by deferred income taxes of $2.1 million. The $15.7 million cash inflow from changes in assets and liabilities resulted from an increase of $24.0 million in accrued liabilities primarily due to higher payroll obligations, and an increase in accounts payable of $4.4 million due to the timing of purchases during the quarter, partially offset by an increase in inventories of $6.9 million to support higher demand from our customers and an increase in accounts receivable of $6.4 million.

 

Investing activities

 

Net cash used in investing activities was $3.7 million in the six months ended June 30, 2013. Cash used in investing activities was primarily attributable to an increase in restricted cash deposits by $47.0 million due to cash designated for the acquisition of IPtronics, purchases of property and equipment of $18.9 million, purchases of intangible assets of $6.3 million and an equity investment of $3.0 million in a private company partially offset by net sales of short-term investments of $72.0 million.

 

Net cash used in investing activities was $156.1 million in the six months ended June 30, 2012. Cash used in investing activities was primarily attributable to net purchases of short-term investments of $144.0 million, purchases of property and equipment of $10.5 million and an equity investment of $1.4 million in a private company.

 

Financing activities

 

Our financing activities generated $8.3 million in the six months ended June 30, 2013. Cash provided by financing activities was primarily due to proceeds of $7.1 million from share option exercises and purchases pursuant to our employee share purchase plan and an excess tax benefit from share-based compensation of $1.9 million, partially offset by principal payments on capital lease obligations of $0.7 million.

 

Our financing activities generated $15.9 million in the six months ended June 30, 2012. Cash provided by financing activities was primarily due to proceeds of $14.3 million from share option exercises and purchases pursuant to our employee share purchase plan and an excess tax benefit from share-based compensation of $1.8 million, partially offset by principal payments on capital lease obligations of $0.2 million.

 

Off-Balance Sheet Arrangements

 

As of June 30, 2013, we did not have any off-balance sheet arrangements.

 

Contractual Obligations

 

The following table summarizes our contractual obligations at June 30, 2013, and the effect those obligations are expected to have on our liquidity and cash flows in future periods:

 

 

 

 

 

Payments Due by Period

 

Contractual Obligations:

 

Total

 

Less Than
 1 Year

 

1-3 Years

 

3-5 Years

 

Beyond 5 Years

 

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

Commitments under capital lease

 

$

3,393

 

$

510

 

$

2,883

 

$

 

$

 

Non-cancelable operating lease commitments

 

57,377

 

16,093

 

20,727

 

11,321

 

9,236

 

Purchase commitments

 

39,572

 

38,143

 

1,279

 

150

 

 

Total

 

$

100,342

 

$

54,746

 

$

24,889

 

$

11,471

 

$

9,236

 

 

For purposes of this table, purchase obligations for the purchase of goods or services are defined as agreements that are enforceable and legally binding and that specify all significant terms including: fixed or minimum purchase quantities; fixed, minimum or variable price provisions; and the approximate timing of the transaction. Our purchase orders are based on our current manufacturing needs and are fulfilled by our vendors within short time horizons. We do not have significant agreements for the purchase of raw materials or other goods specifying minimum quantities or set prices that exceed our expected requirements.

 

30



Table of Contents

 

Recent Accounting Standards

 

See Note 1, “The Company and Summary of Significant Accounting Policies—Recent accounting pronouncements” of the Notes to the Unaudited Condensed Consolidated Financial Statements, included in Part I, Item 1 of this report, for a full description of recent accounting standards, including the respective dates of adoption and effects on our condensed consolidated financial position, results of operations and cash flows.

 

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Interest Rate Fluctuation Risk

 

We do not have any long-term borrowings. Our investments consist of cash and cash equivalents, short-term deposits, and interest bearing investments in U.S. government debt securities and corporate bonds with an average maturity of less than one year. The primary objective of our investment activities is to preserve principal while maximizing income without significantly increasing risk. By policy, we limit the amount of our credit exposure through diversification and restricting our investments to highly rated securities. At the time of purchase, we do not invest more than $7.0 million in individual securities, except U.S. Treasury or agency securities. Highly rated securities are defined as having a minimum Moody or Standard & Poor’s rating of A2 or A, respectively. We have not experienced any material losses on cash equivalents or short-term investments. We do not enter into investments for trading or speculative purposes. Our investments are exposed to market risk due to a fluctuation in interest rates, which may affect our interest income and the fair market value of our investments. Due to the short-term nature of our investment portfolio, we do not believe an immediate 1% change in interest rates would have a material effect on the fair market value of our portfolio, and therefore we do not expect our operating results or cash flows to be materially affected by a sudden change in market interest rates.

 

Foreign Currency Exchange Risk

 

We derive all of our revenues in U.S. dollars. The U.S. dollar is our functional and reporting currency in all of our foreign locations. However, a significant portion of our headcount related expenses, consisting principally of salaries and related personnel expenses, and our Israeli facility expenses are denominated in new Israeli shekels, or NIS. This foreign currency exposure gives rise to market risk associated with exchange rate movements of the U.S. dollar against the NIS. Furthermore, we anticipate that a material portion of our expenses will continue to be denominated in NIS. To the extent the U.S. dollar weakens against the NIS, we will experience a negative impact on our profits.

 

To protect against reductions in the value and the volatility of future cash flows caused by changes in foreign currency exchange rates, we have established a balance sheet and anticipated transaction risk management program. Currency forward contracts and natural hedges are generally utilized in this hedging program. We do not enter into forward contracts for trading or speculative purposes. Our hedging program reduces, but does not eliminate, the impact of currency exchange rate movements (see Part II, Item 1A, “Risk Factors”). If we were to experience a 10% change in currency exchange rates, the impact on assets and liabilities denominated in currencies other than the U.S. dollar, after taking into account hedges and offsetting positions, would result in a loss before taxes of approximately $0.2 million at June 30, 2013. There would also be an impact on future operating expenses denominated in currencies other than the U.S. dollar. At June 30, 2013, approximately $10.3 million of our monthly operating expenses were denominated in NIS. As of June 30, 2013, we had forward contracts in place that hedged future operating expenses of approximately 143.5 million NIS, or approximately $39.7 million based upon the exchange rate on June 30, 2013. The forward contracts cover a portion of future NIS denominated operating expenses expected to occur over the next twelve months. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. However, under current market conditions, failure of one or more of these financial institutions is possible and could result in incurred losses.

 

ITEM 4 — CONTROLS AND PROCEDURES

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

31



Table of Contents

 

As required by Rule 13a-15(b) under the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on the foregoing, our chief executive officer and chief financial officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

 

Changes in Internal Control Over Financial Reporting

 

There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial statements.

 

PART II. OTHER INFORMATION

 

ITEM 1 — LEGAL PROCEEDINGS

 

See Note 7, “Commitments and Contingencies—Legal proceedings” of the Notes to the Unaudited Condensed Consolidated Financial Statements, included in Part I, Item 1 of this report, for a full description of legal proceedings and related contingencies and their effects on our condensed consolidated financial position, results of operations and cash flows.

 

We may, from time to time, become a party to various other legal proceedings arising in the ordinary course of business. We may also be indirectly affected by administrative or court proceedings or actions in which we are not involved, but which have general applicability to the semiconductor industry.

 

ITEM 1A — RISK FACTORS

 

Investing in our ordinary shares involves a high degree of risk. You should carefully consider the following risk factors, in addition to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2012, the other information set forth in this report and our other filings with the SEC, before purchasing our ordinary shares. Each of these risk factors could harm our business, financial condition or operating results, as well as decrease the value of an investment in our ordinary shares.

 

There have been no material changes from risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2012, except for the following:

 

Risks Related to Our Business

 

We may pursue acquisitions of other companies or new or complementary products, technologies and businesses, which could harm our operating results, may disrupt our business and could result in unanticipated accounting charges.

 

On July 1, 2013, we acquired IPtronics and we plan to close the Kotura acquisition in the third quarter of 2013. We may pursue acquisitions of other companies or new or complementary products, technologies and businesses in the future. Acquisitions create additional, material risk factors for our business that could cause our results to differ materially and adversely from our expected or projected results. Such risk factors include the effects of possible disruption to the continued expansion of our product lines, potential changes in our customer base and changes to the total available market for our products, reduced demand for our products, the impact of any such acquisition on our financial results, negative customer reaction to any such acquisition, reduced investment income as a result of lower cash and investment balances and our ability to successfully integrate an acquired company’s operations with our operations.

 

Acquisitions, such as our acquisitions of IPtronics and Kotura present a number of other potential risks and challenges that could disrupt our business operations. For example, we may not be able to successfully negotiate or finance the acquisition on favorable terms. If an acquired company also has inventory that we assume, we will be required to write up the carrying value of that inventory to its fair value. When that inventory is sold, the gross margins for those products are reduced and our gross margins for that period are negatively affected. Furthermore, the purchase price of any acquired businesses may exceed the current fair values of the net tangible assets of such acquired businesses. As a result, we would be required to record material amounts of goodwill, acquired in-process research and development and other intangible assets, which could result in significant impairment and acquired in-process research and development charges and amortization expense in future periods. These charges, in addition to the results of operations of such acquired businesses and potential restructuring costs associated with an acquisition, could have a material adverse effect on our business, financial condition and results of operations. We cannot forecast the number, timing or size of future acquisitions, or the effect that any such acquisitions might have on our operating or financial results. Furthermore, potential acquisitions, whether or not consummated, will divert our management’s attention and may require considerable cash outlays at the expense of our existing operations. In addition, to complete future acquisitions, we may issue equity securities, incur debt, assume contingent liabilities or have amortization expenses and write-downs of acquired assets, which could adversely affect our profitability.

 

We depend on a small number of customers for a significant portion of our sales, and the loss of any one of these customers will adversely affect our revenues.

 

A small number of customers account for a significant portion of our revenues. For the three months ended June 30, 2013, sales to IBM and Hewlett-Packard accounted for 19% and 10%, respectively, of our total revenues, while sales to our top ten customers accounted for 70% of our revenues. For the three months ended June 30, 2012, sales to Hewlett-Packard and IBM accounted for 30% and 19%, respectively, of our total revenues, while sales to our top ten customers accounted for 82% of our revenues. A large Web 2.0 customer contributed to the percentage of our June 30, 2012 quarter revenues from Hewlett-Packard. For the year ended December 31, 2012, sales to Hewlett-Packard and IBM accounted for 20% and 19%, respectively, of our total revenues, while sales to our top ten customers accounted for 74% of our revenues. Because the majority of servers, storage, communications infrastructure equipment and embedded systems are sold by a relatively small number of vendors, we expect that we will continue to depend on a small number of customers to account for a significant percentage of our revenues for the foreseeable future. Our customers, including our most significant customers, are not obligated by long-term contracts to purchase our products and may cancel orders with limited potential penalties. If any of our large customers reduces or cancels its purchases from us for any reason, it could have an adverse effect on our revenues and results of operations.

 

32



Table of Contents

 

Risks Related to Operations in Israel and Other Foreign Countries

 

We are susceptible to additional risks from our international operations.

 

We derived 48% and 55% of our revenues in the three months ended June 30, 2013 and 2012, respectively, from sales outside of North America. As a result, we face additional risks from doing business internationally, including:

 

·               reduced protection of intellectual property rights in some countries;

 

·               difficulties in staffing and managing foreign operations;

 

·               longer sales and payment cycles;

 

·               greater difficulties in collecting accounts receivable;

 

·               adverse economic conditions;

 

·               seasonal reductions in business activity;

 

·               potentially adverse tax consequences;

 

·               laws and business practices favoring local competition;

 

·               costs and difficulties of customizing products for foreign countries;

 

·               compliance with a wide variety of complex foreign laws and treaties;

 

·               compliance with the United States’ Foreign Corrupt Practices Act and similar anti-bribery laws in other jurisdictions;

 

·               compliance with export control and regulations;

 

·               licenses, tariffs, other trade barriers, transit restrictions and other regulatory or contractual limitations on our ability to sell or develop our products in certain foreign markets;

 

·               foreign currency exchange risks;

 

·               fluctuations in freight rates and transportation disruptions;

 

·               political and economic instability;

 

·               variance and unexpected changes in local laws and regulations;

 

·               natural disasters and public health emergencies; and

 

·               trade and travel restrictions.

 

Our principal research and development facilities are located in Israel, and our directors, executive officers and other key employees are located primarily in Israel and the United States. In addition, we engage sales representatives in various countries throughout the world to market and sell our products in those countries and surrounding regions. If we encounter any of the above risks in our international operations, we could experience slower than expected revenue growth and our business could be harmed.

 

Exchange rate fluctuations between the U.S. dollar and the NIS may negatively affect our earnings.

 

Although all of our revenues and a majority of our expenses are denominated in U.S. dollars, a significant portion of our research and development expenses and our Israeli facility expenses are incurred in new Israeli shekels, or NIS. As a result, we are exposed to risk to the extent that the inflation rate in Israel exceeds the rate of devaluation of the NIS in relation to the U.S. dollar, or if the timing

 

33



Table of Contents

 

of these devaluations lags behind inflation in Israel. In that event, the U.S. dollar cost of our research and development operations in Israel will increase and our U.S. dollar-measured results of operations will be adversely affected. To the extent that the value of the NIS increases against the U.S. dollar, our expenses on a U.S. dollar cost basis increase. We cannot predict any future trends in the rate of inflation in Israel or the rate of appreciation of the NIS against the U.S. dollar. If the U.S. dollar cost of our research and development operations and facility expenses in Israel increases, our dollar-measured results of operations will be adversely affected. Our operations also could be adversely affected if we are unable to guard against currency fluctuations in the future. Further, because all of our international revenues are denominated in U.S. dollars, a strengthening of the dollar versus other currencies could make our products less competitive in foreign markets and the collection of our receivables more difficult. To help manage this risk we have been engaged in foreign currency hedging activities. These measures, however, may not adequately protect us from material adverse effects due to the impact of inflation in Israel and changes in value of NIS against the U.S. dollar.

 

Risks Related to Our Ordinary Shares

 

The ownership of our ordinary shares will continue to be highly concentrated, and your interests may conflict with the interests of our existing shareholders.

 

As of June 30, 2013, based on information filed with the SEC or reported to us, Oracle Corporation and certain entities affiliated with Fidelity Management & Research Company, Migdal Insurance and Financial Holdings, Psagot Investments House Ltd. and T. Rowe Price Associates, Inc. beneficially owned an aggregate of approximately 41% of our outstanding ordinary shares, and taken together with our executive officers and directors and their affiliates, beneficially owned an aggregate of approximately 47% of our outstanding ordinary shares. Accordingly, these shareholders, should they act as a group, would have significant influence over the outcome of corporate actions requiring shareholder approval, including the election of directors, any merger, consolidation or sale of all or substantially all of our assets or any other significant corporate transaction. These shareholders could delay or prevent a change of control of our company, even if such a change of control would benefit our other shareholders. The significant concentration of share ownership may adversely affect the trading price of our ordinary shares due to investors’ perception that conflicts of interest may exist or arise.

 

The price of our ordinary shares may continue to be volatile, and the value of an investment in our ordinary shares may decline.

 

During the three months ended June 30, 2013, our shares traded as low as $42.58 and as high as $63.09 per share. During the last 52 weeks our shares traded as low as $41.75 per share and as high as $120.05 per share. Factors that could cause volatility in the market price of our ordinary shares include, but are not limited to:

 

·               quarterly variations in our results of operations or those of our competitors;

 

·               announcements by us, our competitors, our customers or rumors from sources other than our company related to acquisitions, new products, significant contracts, commercial relationships, capital commitments or changes in the competitive landscape;

 

·               our ability to develop and market new and enhanced products on a timely basis;

 

·               disruption to our operations;

 

·               geopolitical instability;

 

·               the emergence of new sales channels in which we are unable to compete effectively;

 

·               any major change in our board of directors or management;

 

·               changes in financial estimates, including our ability to meet our future revenue and operating profit or loss projections;

 

·               changes in governmental regulations or in the status of our regulatory approvals;

 

·               general economic conditions and slow or negative growth of related markets;

 

·               commencement of, or our involvement in, litigation;

 

34



Table of Contents

 

·               changes in earnings estimates or recommendations by securities analysts;

 

·               whether our operating results meet our guidance or the expectations of investors or securities analysts;

 

·               continuing international conflicts and acts of terrorism; and

 

·               changes in accounting rules.

 

We have initiated the process to delist our ordinary shares from the Tel Aviv Stock Exchange (the “TASE”). Although our ordinary shares will continue to be listed on NASDAQ, delisting from the TASE could reduce the trading volume and liquidity of our ordinary shares, which could increase the volatility in the market price of our ordinary shares. In addition, the stock markets in general, and the markets for semiconductor stocks in particular, have experienced extreme volatility that often has been unrelated to the operating performance of the issuer. These broad market fluctuations may adversely affect the trading price or liquidity of our ordinary shares. When the market price of a stock has been volatile and declined, holders of that stock have sometimes instituted securities class action litigation against the issuer. Lawsuits brought against us by shareholders, such as the shareholder class action suits filed in February 2013 against us and certain of our current and former executive officers, could cause us to incur substantial costs defending the lawsuits and divert the attention of our management from the operation of our business.

 

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Not applicable.

 

ITEM 3 — DEFAULTS UPON SENIOR SECURITIES

 

Not applicable.

 

ITEM 4 — MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5 — OTHER INFORMATION

 

None.

 

ITEM 6 — EXHIBITS

 

2.1 (1)

 

Agreement and Plan of Merger, dated May 14, 2013, by and among Mellanox Technologies, Ltd., Mellanox Technologies, Inc., Karate Sub, Inc., Kotura, Inc. and GF Private Equity Group, LLC.

 

 

 

3.1 (2)

 

Amended and Restated Articles of Association of Mellanox Technologies, Ltd. (as amended on May 16, 2011).

 

 

 

10.1(3)

 

IPtronics, Inc. 2013 Restricted Stock Unit Plan.

 

 

 

10.2(4)

 

Form of Restricted Stock Unit Award Agreement under the IPtronics, Inc. 2013 Restricted Stock Unit Plan.

 

 

 

31.1

 

Certification of the Company’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certification of the Company’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1

 

Certification of the Company’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2

 

Certification of the Company’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS (5)

 

XBRL Instance Document

 

 

 

101.SCH (5)

 

XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL (5)

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.LAB (5)

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE (5)

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

101.DEF (5)

 

XBRL Taxonomy Extension Definition Linkbase Document

 

35



Table of Contents

 


(1)

 

Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-33299) filed on May 15, 2013.

 

 

 

(2)

 

Incorporated by reference to Exhibit A to the Company’s Definitive Proxy Statement on Schedule 14A (File No. 001-33299) filed on April 11, 2011.

 

 

 

(3)

 

Incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-8 (File No. 333-189720) filed on July 1, 2013.

 

 

 

(4)

 

Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-8 (File No. 333-189720) filed on July 1, 2013.

 

 

 

(5)

 

Pursuant to Rule 406T of SEC Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, and are deemed not filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under these sections.

 

36



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: August 2, 2013

Mellanox Technologies, Ltd.

 

 

 

/s/ Jacob Shulman

 

Jacob Shulman

 

Chief Financial Officer

 

(Duly Authorized Officer and Principal Financial Officer)

 

37



Table of Contents

 

Exhibit Index

 

2.1 (1)

 

Agreement and Plan of Merger, dated May 14, 2013, by and among Mellanox Technologies, Ltd., Mellanox Technologies, Inc., Karate Sub, Inc., Kotura, Inc. and GF Private Equity Group, LLC.

 

 

 

3.1 (2)

 

Amended and Restated Articles of Association of Mellanox Technologies, Ltd. (as amended on May 16, 2011).

 

 

 

10.1(3)

 

IPtronics, Inc. 2013 Restricted Stock Unit Plan.

 

 

 

10.2(4)

 

Form of Restricted Stock Unit Award Agreement under the IPtronics, Inc. 2013 Restricted Stock Unit Plan.

 

 

 

31.1

 

Certification of the Company’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certification of the Company’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1

 

Certification of the Company’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2

 

Certification of the Company’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS (5)

 

XBRL Instance Document

 

 

 

101.SCH (5)

 

XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL (5)

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.LAB (5)

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE (5)

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

101.DEF (5)

 

XBRL Taxonomy Extension Definition Linkbase Document

 


(1)

 

Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-33299) filed on May 15, 2013.

 

 

 

(2)

 

Incorporated by reference to Exhibit A to the Company’s Definitive Proxy Statement on Schedule 14A (File No. 001-33299) filed on April 11, 2011.

 

 

 

(3)

 

Incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-8 (File No. 333-189720) filed on July 1, 2013.

 

 

 

(4)

 

Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-8 (File No. 333-189720) filed on July 1, 2013.

 

 

 

(5)

 

Pursuant to Rule 406T of SEC Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, and are deemed not filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under these sections.

 

38